 CAMBRIDGE, Mass., March 02, 2022 GLOBE NEWSWIRE -- Sarepta Therapeutics, Inc. NASDAQ:SRPT, the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at three upcoming virtual investor conferences: 